| Product NDC: | 0378-5522 |
| Proprietary Name: | Olanzapine |
| Non Proprietary Name: | olanzapine |
| Active Ingredient(s): | 15 mg/1 & nbsp; olanzapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-5522 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076866 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130426 |
| Package NDC: | 0378-5522-93 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5522-93) |
| NDC Code | 0378-5522-93 |
| Proprietary Name | Olanzapine |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5522-93) |
| Product NDC | 0378-5522 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | olanzapine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130426 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | OLANZAPINE |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |